Rare genetic coding variants associated with human longevity and protection against age-related diseases.


Journal

Nature aging
ISSN: 2662-8465
Titre abrégé: Nat Aging
Pays: United States
ID NLM: 101773306

Informations de publication

Date de publication:
09 2021
Historique:
received: 08 12 2020
accepted: 05 08 2021
medline: 1 9 2021
pubmed: 1 9 2021
entrez: 28 4 2023
Statut: ppublish

Résumé

Extreme longevity in humans has a strong genetic component, but whether this involves genetic variation in the same longevity pathways as found in model organisms is unclear. Using whole-exome sequences of a large cohort of Ashkenazi Jewish centenarians to examine enrichment for rare coding variants, we found most longevity-associated rare coding variants converge upon conserved insulin/insulin-like growth factor 1 signaling and AMP-activating protein kinase signaling pathways. Centenarians have a number of pathogenic rare coding variants similar to control individuals, suggesting that rare variants detected in the conserved longevity pathways are protective against age-related pathology. Indeed, we detected a pro-longevity effect of rare coding variants in the Wnt signaling pathway on individuals harboring the known common risk allele APOE4. The genetic component of extreme human longevity constitutes, at least in part, rare coding variants in pathways that protect against aging, including those that control longevity in model organisms.

Identifiants

pubmed: 37117627
doi: 10.1038/s43587-021-00108-5
pii: 10.1038/s43587-021-00108-5
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

783-794

Subventions

Organisme : NHGRI NIH HHS
ID : R01 HG008153
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061155
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG060747
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057909
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG017242
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG056278
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
pubmed: 23746838 pmcid: 3836174 doi: 10.1016/j.cell.2013.05.039
Kenyon, C. J. The genetics of ageing. Nature 464, 504–512 (2010).
pubmed: 20336132 doi: 10.1038/nature08980
Kirkwood, T. B. Understanding the odd science of aging. Cell 120, 437–447 (2005).
pubmed: 15734677 doi: 10.1016/j.cell.2005.01.027
Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183–192 (2019).
pubmed: 31292558 pmcid: 7205183 doi: 10.1038/s41586-019-1365-2
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A. C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).
pubmed: 8247153 doi: 10.1038/366461a0
Ayyadevara, S., Alla, R., Thaden, J. J. & Shmookler Reis, R. J. Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell 7, 13–22 (2008).
pubmed: 17996009 doi: 10.1111/j.1474-9726.2007.00348.x
Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110 (2001).
pubmed: 11292875 doi: 10.1126/science.1057987
Clancy, D. J. et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104–106 (2001).
pubmed: 11292874 doi: 10.1126/science.1057991
Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182–187 (2003).
pubmed: 12483226 doi: 10.1038/nature01298
Johnson, S. C., Rabinovitch, P. S. & Kaeberlein, M. mTOR is a key modulator of ageing and age-related disease. Nature 493, 338–345 (2013).
pubmed: 23325216 pmcid: 3687363 doi: 10.1038/nature11861
Herskind, A. M. et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum. Genet. 97, 319–323 (1996).
pubmed: 8786073 doi: 10.1007/BF02185763
Vijg, J. & Suh, Y. Genetics of longevity and aging. Annu. Rev. Med. 56, 193–212 (2005).
pubmed: 15660509 doi: 10.1146/annurev.med.56.082103.104617
Christensen, K., Johnson, T. E. & Vaupel, J. W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436–448 (2006).
pubmed: 16708071 pmcid: 2726954 doi: 10.1038/nrg1871
Perls, T. T., Bubrick, E., Wager, C. G., Vijg, J. & Kruglyak, L. Siblings of centenarians live longer. Lancet 351, 1560 (1998).
pubmed: 10326548 doi: 10.1016/S0140-6736(05)61126-9
Melzer, D., Pilling, L. C. & Ferrucci, L. The genetics of human ageing. Nat. Rev. Genet. 21, 88–101 (2020).
pubmed: 31690828 doi: 10.1038/s41576-019-0183-6
Zhang, Z. D. et al. Genetics of extreme human longevity to guide drug discovery for healthy ageing. Nat. Metab. 2, 663–672 (2020).
Deelen, J. et al. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age 35, 235–249 (2013).
pubmed: 22113349 doi: 10.1007/s11357-011-9340-3
Broer, L. et al. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J. Gerontol. A 70, 110–118 (2015).
doi: 10.1093/gerona/glu166
Deelen, J. et al. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat. Commun. 10, 3669 (2019).
pubmed: 31413261 pmcid: 6694136 doi: 10.1038/s41467-019-11558-2
Cash, T. P. et al. Exome sequencing of three cases of familial exceptional longevity. Aging Cell 13, 1087–1090 (2014).
pubmed: 25116423 pmcid: 4326919 doi: 10.1111/acel.12261
Nygaard, H. B. et al. Whole-exome sequencing of an exceptional longevity cohort. J. Gerontol. A Biol. Sci. Med. Sci. 74, 1386–1390 (2018).
Shindyapina, A. V. et al. Germline burden of rare damaging variants negatively affects human healthspan and lifespan. eLife 9, e53449 (2020).
pubmed: 32254024 pmcid: 7314550 doi: 10.7554/eLife.53449
Guha, S. et al. Implications for health and disease in the genetic signature of the Ashkenazi Jewish population. Genome Biol. 13, R2 (2012).
pubmed: 22277159 pmcid: 3334583 doi: 10.1186/gb-2012-13-1-r2
Hunt, R. C., Simhadri, V. L., Iandoli, M., Sauna, Z. E. & Kimchi-Sarfaty, C. Exposing synonymous mutations. Trends Genet. 30, 308–321 (2014).
pubmed: 24954581 doi: 10.1016/j.tig.2014.04.006
Lee, S., Abecasis, G. R., Boehnke, M. & Lin, X. Rare-variant association analysis: study designs and statistical tests. Am. J. Hum. Genet. 95, 5–23 (2014).
pubmed: 24995866 pmcid: 4085641 doi: 10.1016/j.ajhg.2014.06.009
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886–D894 (2019).
doi: 10.1093/nar/gky1016 pubmed: 30371827
Sundaram, L. et al. Predicting the clinical impact of human mutation with deep neural networks. Nat. Genet. 50, 1161–1170 (2018).
pubmed: 30038395 pmcid: 6237276 doi: 10.1038/s41588-018-0167-z
Fafian-Labora, J. et al. FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis. 10, 318 (2019).
pubmed: 30962418 pmcid: 6453932 doi: 10.1038/s41419-019-1550-0
Brosh, R. M. Jr. & Bohr, V. A. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 35, 7527–7544 (2007).
pubmed: 18006573 pmcid: 2190726 doi: 10.1093/nar/gkm1008
Lin, J. R., Zhang, Q., Cai, Y., Morrow, B. E. & Zhang, Z. D. Integrated rare variant-based risk gene prioritization in disease case-control sequencing studies. PLoS Genet. 13, e1007142 (2017).
pubmed: 29281626 pmcid: 5760082 doi: 10.1371/journal.pgen.1007142
Tasan, M. et al. Selecting causal genes from genome-wide association studies via functionally coherent subnetworks. Nat. Methods 12, 154–159 (2015).
pubmed: 25532137 doi: 10.1038/nmeth.3215
Lupton, M. K. et al. The role of ABCA1 gene sequence variants on risk of Alzheimer’s disease. J. Alzheimers Dis. 38, 897–906 (2014).
pubmed: 24081377 doi: 10.3233/JAD-131121
Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat. Genet. 49, 1373–1384 (2017).
pubmed: 28714976 pmcid: 5669039 doi: 10.1038/ng.3916
Liu, D. J. & Leal, S. M. Replication strategies for rare variant complex trait association studies via next-generation sequencing. Am. J. Hum. Genet. 87, 790–801 (2010).
pubmed: 21129725 pmcid: 2997372 doi: 10.1016/j.ajhg.2010.10.025
Beecham, G. W. et al. The Alzheimer’s Disease Sequencing Project: study design and sample selection. Neurol. Genet. 3, e194 (2017).
pubmed: 29184913 pmcid: 5646177 doi: 10.1212/NXG.0000000000000194
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
pubmed: 27535533 pmcid: 5018207 doi: 10.1038/nature19057
Mahley, R. W. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J. Mol. Med. 94, 739–746 (2016).
pubmed: 27277824 doi: 10.1007/s00109-016-1427-y
Erikson, G. A. et al. Whole-genome sequencing of a healthy aging cohort. Cell 165, 1002–1011 (2016).
pubmed: 27114037 pmcid: 4860090 doi: 10.1016/j.cell.2016.03.022
Eichner, J. E. et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 155, 487–495 (2002).
pubmed: 11882522 doi: 10.1093/aje/155.6.487
Liu, H. et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317, 803–806 (2007).
pubmed: 17690294 doi: 10.1126/science.1143578
Kirkwood, T. B. & Finch, C. E. Ageing: the old worm turns more slowly. Nature 419, 794–795 (2002).
pubmed: 12397339 doi: 10.1038/419794a
Kirkwood, T. B. et al. What accounts for the wide variation in life span of genetically identical organisms reared in a constant environment? Mech. Ageing Dev. 126, 439–443 (2005).
pubmed: 15664632 doi: 10.1016/j.mad.2004.09.008
Caruso, A. et al. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J. Neurochem. 98, 364–371 (2006).
pubmed: 16805831 doi: 10.1111/j.1471-4159.2006.03867.x
Klaus, A. & Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8, 387–398 (2008).
pubmed: 18432252 doi: 10.1038/nrc2389
Palomer, E., Buechler, J. & Salinas, P. C. Wnt signaling deregulation in the aging and Alzheimer’s brain. Front. Cell Neurosci. 13, 227 (2019).
pubmed: 31191253 pmcid: 6538920 doi: 10.3389/fncel.2019.00227
Ng, L. F. et al. WNT signaling in disease. Cells 8, 826 (2019).
pmcid: 6721652 doi: 10.3390/cells8080826
Timmers, P. R. et al. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances. eLife 8, e39856 (2019).
Yang, J. et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age 35, 11–22 (2013).
doi: 10.1007/s11357-011-9324-3 pubmed: 22081425
Piazzesi, A. et al. Replication-independent histone variant H3.3 controls animal lifespan through the regulation of pro-longevity transcriptional programs. Cell Rep. 17, 987–996 (2016).
pubmed: 27760329 pmcid: 5081402 doi: 10.1016/j.celrep.2016.09.074
Reichwald, K. et al. High tandem repeat content in the genome of the short-lived annual fish Nothobranchius furzeri: a new vertebrate model for aging research. Genome Biol. 10, R16 (2009).
pubmed: 19210790 pmcid: 2688266 doi: 10.1186/gb-2009-10-2-r16
Course, M. M. et al. Evolution of a human-specific tandem repeat associated with ALS. Am. J. Hum. Genet. 107, 445–460 (2020).
pubmed: 32750315 pmcid: 7477013 doi: 10.1016/j.ajhg.2020.07.004
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Dewey, F. E. et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123–1133 (2016).
pubmed: 26933753 pmcid: 4900689 doi: 10.1056/NEJMoa1510926
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836 doi: 10.1038/ng.3656
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
pubmed: 27548312 pmcid: 5388176 doi: 10.1038/ng.3643
Euesden, J., Lewis, C. M. & O’Reilly, P. F. PRSice: polygenic risk score software. Bioinformatics 31, 1466–1468 (2015).
pubmed: 25550326 doi: 10.1093/bioinformatics/btu848
Choi, S. W. & O’Reilly, P. F. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience 8, giz082 (2019).
pubmed: 31307061 pmcid: 6629542 doi: 10.1093/gigascience/giz082
Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
Nikpay, M. et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121–1130 (2015).
pubmed: 26343387 pmcid: 4589895 doi: 10.1038/ng.3396
Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505–1513 (2018).
pubmed: 30297969 pmcid: 6287706 doi: 10.1038/s41588-018-0241-6
Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524–537 (2018).
pubmed: 29531354 pmcid: 5968830 doi: 10.1038/s41588-018-0058-3
Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet. 50, 928–936 (2018).
pubmed: 29892016 pmcid: 6568012 doi: 10.1038/s41588-018-0142-8
Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92–94 (2017).
pubmed: 29059683 pmcid: 5798588 doi: 10.1038/nature24284
Wolpin, B. M. et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat. Genet. 46, 994–1000 (2014).
pubmed: 25086665 pmcid: 4191666 doi: 10.1038/ng.3052
Wang, X. Firth logistic regression for rare variant association tests. Front. Genet. 5, 187 (2014).
pubmed: 24995013 pmcid: 4063169
Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82–93 (2011).
pubmed: 21737059 pmcid: 3135811 doi: 10.1016/j.ajhg.2011.05.029
Flannick, J. et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570, 71–76 (2019).
pubmed: 31118516 pmcid: 6699738 doi: 10.1038/s41586-019-1231-2
Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305–W311 (2009).
pubmed: 19465376 pmcid: 2703978 doi: 10.1093/nar/gkp427
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
pubmed: 27141961 pmcid: 4987924 doi: 10.1093/nar/gkw377
Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191–W198 (2019).
pubmed: 31066453 pmcid: 6602461 doi: 10.1093/nar/gkz369
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Oakes, D. & Peterson, D. R. Survival methods: additional topics. Circulation 117, 2949–2955 (2008).
pubmed: 18519862 doi: 10.1161/CIRCULATIONAHA.107.700377
Chen, H. et al. Comprehensive assessment of computational algorithms in predicting cancer driver mutations. Genome Biol. 21, 43 (2020).
pubmed: 32079540 pmcid: 7033911 doi: 10.1186/s13059-020-01954-z
Flachsbart, F. et al. Immunochip analysis identifies association of the RAD50/IL13 region with human longevity. Aging Cell 15, 585–588 (2016).
pubmed: 27004735 pmcid: 4854908 doi: 10.1111/acel.12471
Muller, N. et al. IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans. J. Lipid. Res. 56, 1034–1042 (2015).
pubmed: 25713100 pmcid: 4409280 doi: 10.1194/jlr.P052209
Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature 586, 749–756 (2020).
pubmed: 33087929 pmcid: 7759458 doi: 10.1038/s41586-020-2853-0

Auteurs

Jhih-Rong Lin (JR)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Patrick Sin-Chan (P)

Regeneron Pharmaceuticals Inc., New York, NY, USA.

Valerio Napolioni (V)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.

Guillermo G Torres (GG)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Joydeep Mitra (J)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Quanwei Zhang (Q)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

M Reza Jabalameli (MR)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Zhen Wang (Z)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Nha Nguyen (N)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Tina Gao (T)

Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.

Matthias Laudes (M)

Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Internal Medicine I, Kiel University, Kiel, Germany.

Siegfried Görg (S)

Institute of Transfusion Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.

Andre Franke (A)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Almut Nebel (A)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Michael D Greicius (MD)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.

Gil Atzmon (G)

Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Department of Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.

Kenny Ye (K)

Department of Epidemiology & Population Health, Albert Einstein College of Medicine, New York, NY, USA.

Vera Gorbunova (V)

Department of Biology, University of Rochester, Rochester, NY, USA.

Warren C Ladiges (WC)

Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA.

Alan R Shuldiner (AR)

Regeneron Pharmaceuticals Inc., New York, NY, USA.

Laura J Niedernhofer (LJ)

Institute on the Biology of Aging and Metabolism and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.

Paul D Robbins (PD)

Institute on the Biology of Aging and Metabolism and Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.

Sofiya Milman (S)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.

Yousin Suh (Y)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA.

Jan Vijg (J)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.

Nir Barzilai (N)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA.
Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.

Zhengdong D Zhang (ZD)

Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA. zhengdong.zhang@einsteinmed.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH